VEGFA and breast carcinoma: Furthermore, an elevated expression of ET-1 and ETAR in breast carcinoma patients is associated with lower survival [239], VEGF expression and angiogenesis [240] and predicts an unfavorable response to neoadjuvant chemotherapy in locally advanced tumors [241].